Novo Nordisk
NVO
#19
Rank
ยฃ377.20 B
Marketcap
ยฃ83.09
Share price
-1.49%
Change (1 day)
4.66%
Change (1 year)

Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.

Novo Nordisk (NVO) - Net assets

Net assets on the balance sheet as of September 2024 : ยฃ14.24 Billion

According to Novo Nordisk's latest financial reports the company has ยฃ14.24 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Novo Nordisk - Net assets on balance sheet (from 2001 to 2024)

Net assets by year

Year Net assets Change
2023-12-31$ยฃ12.38 B24.65%
2022-12-31$ยฃ9.93 B24.54%
2021-12-31$ยฃ7.97 B3.91%
2020-12-31$ยฃ7.67 B16.62%
2019-12-31$ยฃ6.58 B5.24%
2018-12-31$ยฃ6.25 B5.3%
2017-12-31$ยฃ5.94 B14.39%
2016-12-31$ยฃ5.19 B11.84%
2015-12-31$ยฃ4.64 B9.88%
2014-12-31$ยฃ4.22 B-11.53%
2013-12-31$ยฃ4.77 B7.19%
2012-12-31$ยฃ4.45 B6.2%
2011-12-31$ยฃ4.19 B-1.78%
2010-12-31$ยฃ4.27 B0.46%
2009-12-31$ยฃ4.25 B0.43%
2008-12-31$ยฃ4.23 B33.43%
2007-12-31$ยฃ3.17 B16.39%
2006-12-31$ยฃ2.72 B7.65%
2005-12-31$ยฃ2.53 B0.11%
2004-12-31$ยฃ2.53 B5.81%
2003-12-31$ยฃ2.39 B16.48%
2002-12-31$ยฃ2.05 B3.09%
2001-12-31$ยฃ1.99 B

Net assets for similar companies or competitors

Company Net assets differencediff. Country
ยฃ73.02 B 412.66%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ11.29 B-20.68%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ13.57 B-4.73%๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ61.73 B 333.42%๐Ÿ‡ซ๐Ÿ‡ท France